Metropolitan Bank Reports Mixed Q2: Strong Capital & NII Growth Offset by Surging Loan Losses
MCB sits 43% above its 52-week low of $64.66.
Summary
Metropolitan Bank Holding Corp. reported strong capital growth from a Q1 equity offering and increased net interest income, but these positives were tempered by a significant rise in loan loss provisions and net charge-offs in Q2 2026.
Key Events · Earnings and Guidance · MCB
-
Strong Capital Position Post-Equity Offering
The company's capital ratios significantly improved, with Tier 1 leverage increasing to 11.3% (from 9.5% at Dec 31, 2025) and Common Equity Tier 1 to 12.9% (from 10.7%), largely due to a $186.5 million public equity offering completed in Q1 2026.
-
Significant Increase in Loan Loss Provision & Charge-offs
Provision for credit losses surged to $13.3 million in Q2 2026 (up from $6.4 million YoY), primarily due to a single C&I loan. Net charge-offs for the six months ended June 30, 2026, were $46.7 million, a substantial increase from $76,000 in the prior year period.
-
Net Interest Income and Margin Expansion
Net interest income increased by $16.8 million to $90.4 million in Q2 2026 (up from $73.6 million YoY) and $35.8 million to $176.4 million YTD. Net interest margin expanded to 4.08% in Q2 2026, reflecting a decline in short-term interest rates.
-
New Share Repurchase Program Authorized
The Board of Directors approved a new $50 million share repurchase program, replacing the previously authorized program. This signals ongoing commitment to shareholder returns.
Analysis · MCB · Finance
This quarterly report reveals a mixed financial picture for Metropolitan Bank. While the company significantly strengthened its capital base through a $186.5 million equity offering in Q1 2026 and saw robust growth in net interest income, it also experienced a substantial increase in loan losses and net charge-offs. The improved capital ratios provide a buffer against these credit quality concerns, but the deterioration in loan performance is a key area for investors to monitor.
At the time of this filing, MCB was trading at $92.47 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $64.66 to $102.04. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.